Vet Pathol Download to Citation Manager
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shtrasburg, S.
Right arrow Articles by Livneh, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shtrasburg, S.
Right arrow Articles by Livneh, A.
Vet Pathol 42:132-139 (2005)
© 2005 American College of Veterinary Pathologists

An Ancillary Tool for the Diagnosis of Amyloid A Amyloidosis in a Variety of Domestic and Wild Animals

S. Shtrasburg, R. Gal, E. Gruys, S. Perl, B. M. Martin, B. Kaplan, R. Koren, A. Nyska, M. Pras and A. Livneh

Heller Institute of Medical Research, Sheba Medical Center, Tel-Hashomer, Israel (SS, BK, MP, AL); Department of Pathology, Golda Campus, Rabin Medical Center, Petach-Tiqva, Israel (RG, RK); Department of Veterinary Pathology, University of Utrecht, Utrecht, The Netherlands (EG); Kimron Veterinary Institute, Beit-Dagan, Israel (SP); Laboratory of Toxicology, National Institute of Mental Health, National Institutes of Health, Bethesda, MD (BMM); Laboratory of Experimental Pathology, National Institute of Environmental Health and Sciences, Research Triangle Park, NC (AN); and Sackler Faculty of Medicine, Tel Aviv University, Israel (SS, RG, RK, MP, AL)


   Abstract
Top
 Abstract
Materials and Methods
 Results
 Discussion
 References
 
Immunohistochemistry, the standard method for diagnosing amyloid A (AA) amyloidosis, is limited in animals because it requires a large array of animal-specific anti-AA antibodies, not commercially available. The Shtrasburg method (SH method) is a highly specific and sensitive technique, helping in the diagnosis and determination of AA amyloidosis in humans. The aim of this study is to determine whether the SH method is applicable in the diagnosis of AA amyloidosis in a variety of animals. Tissue samples were obtained from animals suffering from spontaneous or experimentally induced AA amyloidosis (mice, hamsters, guinea pigs, cheetahs, cats, cows, ducks, a dog, a goose, a chicken, and a turaco). Detection of the amyloid and quantitative evaluation were performed using Congo red staining, and specific AA typing was performed by the potassium permanganate technique. The studied tissues were subjected to the SH method, which confirmed the AA nature of the amyloid deposit, by displaying in polyacrylamide gel electrophoresis protein bands consistent with the molecular weight of the species-specific AA, in all the animals examined, except mice, hamsters, and guinea pigs. N-terminal analysis of these bands corroborated their AA origin. We conclude that the SH method may be used as an ancillary simple tool for the diagnosis of AA amyloidosis in a large number of domestic and wild animals. Moreover, our findings further increase the feasibility of applying this method in humans.

Key words: AA amyloidosis; amyloid A; amyloid-enhancing factor; animal model; N-terminal sequence analysis; reactive amyloidosis; the Shtrasburg method.

Amyloidosis is a disease characterized by extracellular deposition of amyloid, a fibrillar material composed of a major protein and common elements.15,20 Amyloid fibrils are usually identified by their unique feature of displaying green birefringence under polarized light37 after Congo red staining. The amyloid deposit is categorized by its major component, which is determined by the underlying disease.4 Often, the diagnosis of the amyloid-inducing disease depends on the elucidation of the amyloid type, usually carried out histologically, using immunohistochemical techniques or by the potassium permanganate method.8,12,29,39,48 When these methods give inconclusive results, caused by cross-reactivity of the antibodies with nonspecific epitopes, unavailability of specific anti-AA antibodies, or inconsistent results of the permanganate assay, complementary methods should be applied.

Reactive amyloidosis is a condition that complicates a long list of chronic inflammatory, chronic infectious, malignant, and hereditary disorders.13,16,52 The main protein involved in this disease is amyloid A (AA), an N-terminal fragment of serum amyloid A (SAA), a serum protein with an explosive rise and a role in inflammation.17,24 The identification of AA is usually based on its reactivity with specific anti-AA antibodies and sensitivity to permanganate pretreatment.12,39,48,51

In 1982, we reported an additional method to identify AA and distinguish it from other amyloid types.47 This method was based on the ability of AA, unlike other amyloid proteins, to undergo extraction from formalin-fixed, paraffin-embedded tissue and retain its electrophoretic and antigenic properties despite formalin masking.25,34,50 Over the years, the Shtrasburg method (SH method) became well established6,9,12,28,35,38,40 and was applied for AA identification,1,2,10,33,53 isolation, and even purification for amino acid sequencing.3,26,27,34

Recently, the SH method has been reevaluated and found to be highly sensitive and specific. It even recognized a range of human AA proteins, which differ in length and composition from the classical 76 amino acid protein in humans, but did not detect various non-AA amyloid proteins, such as light chains, senile and familial transthyretin, ß2-microglobulin, calcitonin of medullary carcinoma of the thyroid, and senile amyloid of the seminal vesicle.21,43

To further expand the spectrum of AA proteins detected by this assay and to determine whether it retains its sensitivity for AA proteins, we studied and report in this study the application of the SH method to amyloidotic tissues of a variety of animals. In this study, the SH method emerges as a novel tool, helpful in the diagnosis of AA amyloidosis in domestic and wild animals.


   Materials and Methods
Top
 Abstract
 Materials and Methods
Results
 Discussion
 References
 
General experimental design

Animal tissues, containing amyloid deposits that were formed spontaneously or induced experimentally, were studied by the SH method.

Experimental animals

Seven- to 16-week-old male and female Swiss mice (Table 1, case Nos. 1–3), 12-week-old male C57Bl, C3H, and AKR mice (case Nos. 4–6), 5- to 6-week-old male golden hamsters (case Nos. 7 and 8), and 4-week-old male guinea pigs (case No. 10) were purchased from the Breeding Colony of Lewenstein, Yokneam, Israel, and subjected to amyloid induction. Care and use of all laboratory animals were in agreement with the criteria set by the animal experimentation committee of the Sheba Medical Center.


View this table:
[in this window]
[in a new window]
  		Table 1. Tinctorial features of the amyloidotic tissues studied by Congo red staining and permanganate technique.

 
Induction of amyloidosis by casein

Amyloidosis was induced by casein in male Swiss mice, hamsters, and guinea pigs (Table 1, case Nos. 1, 7, and 10) according to established protocols.5,15 In brief, mice were injected subcutaneously (s.c.) 5 days a week for 3 weeks with 0.5 ml/day of 15% (wt/vol) vitamin-free casein (NBC, Cleveland, OH) suspended in 0.02 mol/liter NaOH. Hamsters (case No. 7) were treated with 1 ml/day of the s.c. casein, three times a week for 8 weeks, and the guinea pigs (case No. 10) received 2 ml/day s.c. injections of the casein preparation two to three times a week for 8 weeks. After these treatments, the animals were euthanatized; one half of their spleen was evaluated for the presence and amount of amyloid, using the crush and smear (C&S) technique,41 and the other half was fixed in 10% formalin (4% formaldehyde), processed, and embedded in paraffin for histologic evaluation. Congo red, with or without permanganate treatment, and the SH method were used for amyloid assessment.

Preparation of amyloid-enhancing factor

Amyloid-enhancing factor (AEF) was prepared as published earlier.42,44 In brief, splenic tissues from preamyloidotic mice were homogenized in 50% acetone/H2O and centrifuged. The sediment was dialyzed against H2O and lyophilized and was found to be extremely active and capable of inducing amyloidogenesis in mice.42,45

Induction of amyloidosis by AEF

Amyloidosis was induced in male and female mice and in a male hamster (Table 1, case Nos. 2, 4–6, 8), using a modification of our standard amyloid induction protocol.42,46 In brief, for mice, a single intravenous injection of 1 µg AEF, suspended in 0.5 ml phosphate-buffered saline, was given, followed by three daily s.c. injections of 0.5 ml AgNO3 2% (wt/vol). The mice were euthanatized on days 14–16, and the amyloid in their spleen was studied as described previously. The longer protocol (14–16 days, instead of 6 days) was applied to generate larger amounts of amyloid deposits. In the male hamster, AEF was injected intraperitoneally in a dose of 200 µg, and 2% (wt/vol) AgNO3 was given s.c., 1 ml every other day for 13 days. The hamster was euthanatized 3 weeks after the last AgNO3 injection, and its amyloid was studied as in the mice.

Tissues from animals with natural amyloidosis

Tissue samples containing amyloid deposits from a variety of animals with natural (spontaneous) amyloidosis were obtained (Table 1, case Nos. 3, 9, 11–27). In all, amyloidosis was diagnosed, and the amyloid quantity was evaluated using the regular Congo red (Bennhold's) method.37,41 All were classified as AA amyloidosis on the basis of clinical diagnosis and/or the potassium permanganate method.51 In addition, the amyloid of cheetah I (Acinonyx jubatus, case No. 12) was diagnosed as AA using monoclonal anti-AA antibodies and immunohistochemistry.33 Ducks I–IV (case Nos. 19–22), chicken (case No. 26), and cat III (case No. 16) amyloids were confirmed as AA by amino acid sequencing.14,23,32 The amyloid of the aged female hamsters (case No. 9) was defined as AA on the basis of previous publications.7,30,31 In this study, the AA nature of amyloid deposits in the tissues of the remaining animals was determined by N-terminal sequencing analysis (see below).

Quantification of amyloid deposits

Semiquantification of amyloid deposits was performed in unfixed tissues from the experimental animals using the C&S technique with a 5-grade scale.41,42 In the formalin-fixed, paraffin-embedded tissues, evaluation of the amyloid amount was based on Congo red staining and a 5-grade scale, comparable to that of the C&S method.41–43

SH method

The SH method is intended to identify AA and distinguish it from other types of amyloid proteins. It was performed as published previously.43,47 In brief, formalin-fixed, paraffin-embedded tissue samples were deparaffinized by melting at 65°C and serial overnight washings with xylol, absolute and 95% ethanol, and saline. The treated specimens were then homogenized, washed in saline, and frozen and thawed several times. Sodium dodecyl sulfate (SDS) sample buffer was then added, and the samples were heated, centrifuged, and the supernatants were subjected to Sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE). Processing and running were repeated at least twice for each sample studied. Negative control samples consisted of organs from nonamyloidotic animals of the same species.

Sodium dodecyl sulfate–polyacrylamide gel electrophoresis

SDS-PAGE was performed in 17% polyacrylamide gel, containing 0.1% SDS, in Tris-glycine running buffer.11,22 Human AA protein, purified from an amyloidotic spleen of a familial Mediterranean fever patient,11,43 recombinant human apo-SAA protein (PeproTech Inc., Rocky Hill, NJ), and Dalton Mark VII-L molecular weight (MW) standards, with an MW ladder of 14.2, 20.1, 24, 29, 36, 45, and 66 kd (Sigma Chemical Co., St. Louis, MO), were used as reference.11,42,43

N-terminal sequence analysis

Samples obtained by the SH method were run on SDS-PAGE and electroblotted on Sequi-Blot polyvinylidene difluoride (PVDF) membranes using 10 mmol/liter 3-cyclo-hexyl-amino-1-propanesulphonic acid (Sigma) buffer (pH 11) containing 10% methanol and stained with 0.5% Coomassie Blue R250 (BioRad, Melville, NY) in 40% methanol/1% acetic acid. The protein bands were excised from the PVDF membrane, and the amino acid sequence analysis was performed using an Applied Biosystem Procise protein sequencer, run in pulsed liquid mode, according to the manufacturer's protocol. Phenylthiohydantoin (PTH)-amino acids were identified online from a 5-pmol PTH-amino acid standard. Database searches were done against the Swiss Prot Database.


   Results
Top
 Abstract
 Materials and Methods
 Results
Discussion
 References
 
Table 1 shows the tinctorial features of the tissues that were studied by the Congo red and permanganate assays. All animals suffered from reactive (AA) amyloidosis with a moderate to large amount of amyloid deposits. This was verified by medical history, Congo red staining, sensitivity to permanganate treatment, and AA sequencing. Our findings demonstrated that in reactive amyloidosis of mice (case Nos. 1–6) and guinea pigs (case No. 10), the sensitivity of the AA for permanganate treatment is inconsistent, and in hamsters (case Nos. 7–9), although the Congo red staining is weak, the amyloid deposits remain permanganate sensitive. Table 2 shows the N-terminal sequences of the amyloid proteins extracted from the studied tissues. These include the amyloid proteins of cheetah II (case No. 13), cat III (case No. 16), ducks V and VI (case Nos. 23 and 24), a goose (case No. 25), and a turaco (a bird of the Musophagide family, case No. 27). As mentioned (see Materials and Methods), the amyloid proteins of cheetah I (case No. 12), cat III (case No. 16), ducks I–IV (case Nos. 19–22), and the chicken (case No. 26) were previously studied and published.14,23,32,33 The N-terminal of the AA protein of the dog (case No. 11) and the cow (case No. 18) was found to be blocked. The amino acid sequences obtained were homologous to published sequences of the appropriate AA protein subunits, with the exception of the turaco (case No. 27), which could not be found in any database but appeared to be consistent with a sequence of an AA protein.


View this table:
[in this window]
[in a new window]
  		Table 2. N-terminal amino acid sequences of the amyloid protein bands.

 
Samples of the formalin-fixed, paraffin-embedded amyloidotic tissues with an amyloid grade above +2, were subjected to amyloid evaluation by the SH method. Normal tissues from the same organ of nonamyloidotic subjects of the same species were studied as negative control. As seen in Table 3, bands consistent with the specific animal AA by its MW appeared in all specimens from the amyloidotic tissues, except those of the mice (case Nos. 1–6), hamsters (case Nos. 7 and 9), and guinea pigs (case No. 10). These are the same animals in which the results of permanganate or Congo red staining were inconsistent. Of interest, the amyloid deposits of the dog (case No. 11), the two cheetahs (case Nos. 12 and 13), cat II (case No. 15), cow I (case No. 17), the chicken (case No. 26), and the turaco (case No. 27) contained two fragment sizes of the AA protein (two bands, Table 3). In cheetah II (case No. 13), the N-terminal of the two protein bands was sequenced and showed, as expected, the same sequence. Similarly, the N-terminal sequences of the two protein bands of the turaco (case No. 27) were identical (Table 2). Figure 1 shows some examples of the SDS-PAGE of extracts of the tissues studied, which were positive by the SH method.


View this table:
[in this window]
[in a new window]
  		Table 3. Shtrasburg (SH) method is positive in most animals studied.

 

Figure 01
View larger version (22K):
[in this window]
[in a new window]
  		Fig. 1. Polyacrylamide gel electrophoresis of extract samples from amyloid-containing tissues, using the SH method. Lane 1: MW markers from top to bottom—66, 45, 36, 29, 24, 20.1, and 14.2 kd. Lane 2: upper band, recombinant human apo SAA (11.7 kd); lower band, purified human AA protein (8.5 kd). Lanes 3–8, extracts from amyloidotic liver of a duck (case No. 23); liver of a goose (case No. 25); liver of a cow (case No. 18); spleen of a duck (case No. 24); liver of a cheetah (case No. 13); and spleen of a turaco (case No. 27), respectively. The bands appearing in lanes 3–8 present amyloid proteins. Note that samples 7 and 8 demonstrate two amyloid protein bands on the gel.

 

   Discussion
Top
 Abstract
 Materials and Methods
 Results
 Discussion
References
 
The usefulness of the SH method in the diagnosis of reactive amyloidosis in a number of animal species was evaluated. The diagnosis of amyloidosis of the AA type in these animals was based on clinical history, permanganate assay, and amino acid sequencing (Tables 1, 2). In cheetah I (case No. 12), it was confirmed by the cross-reactive monoclonal anti-human AA antibodies mc4 and mc29 (Table 1).33 In all animals studied, except for the mouse, hamster, and guinea pig, the SH method gave positive results, namely, extracts of amyloid-containing tissues displayed distinct protein bands in SDS-PAGE (Table 3, Fig. 1). The decision that these protein bands are the amyloid proteins of the AA amyloidotic animals was based on the results of the N-terminal amino acid sequence analysis of the bands (Table 2), the absence of protein bands in negative control tissues, and the size of the specific animal AA protein.18,23,32,49,52

In the mice (case Nos. 1–6), hamsters (case Nos. 7 and 9), and guinea pigs (case No. 10), the SH method failed to demonstrate protein bands and therefore cannot be applied for the diagnosis of reactive amyloidosis in these animals. The insensitivity of the SH method to AA in these animals is not related to the amount of amyloid deposition or to the mode of its generation (spontaneous or experimental). This is inferred from the finding that the SH method gave negative results both in experimental amyloidosis, (generated either by AEF or by casein), and in spontaneous (natural) amyloidosis with chronic inflammatory skin lesions (case No. 3) or of naive, aged, female hamsters (Table 3, case No. 9).

A high degree of structural homology of SAA, the precursor protein of AA, is known to exist between species, particularly in positions 36–58 and 94–105.17,19 An attempt to discern structural differences in animals' AA, separating mice and hamsters from all the other animals examined, revealed only two sites with such amino acid sequence variability (we could not find a published sequence of the AA of the guinea pig beyond position 20). One change is in serine in position 22,32 which is substituted by threonine in the AA of the mouse and hamster. The other change is in position 65. This site is highly versatile in many animals, but only in the mouse and hamster does phenylalanine substitute for isoleucine, which is found in human AA. The difference in position 22 is unlikely to cause a significant change in the nature of the AA protein or to affect its binding to other tissue components because both serine and threonine are neutral and polar amino acids and closely resemble each other in their structure. The role of the change in position 65 is hard to predict, but it may be more important because the two amino acids are structurally different.

Additional factors that could have determined the inaccessibility of the AA protein of these three species to the SH method are the other constituents of the amyloid fibril, which in mice, hamsters, and guinea pigs may disrupt AA extractability. Moreover, it is possible that the nonsusceptibility of the amyloid of these animals to the SH method and the insensitivity to the potassium permanganate assay (Table 1) share a common mechanism. This hypothesis concurs with that of Mezza et al.,30 who demonstrated insusceptibility to permanganate treatment in hamster amyloidotic tissues as well. Because Congo red staining is structurally dependent, it could be inferred that structural changes in the ß-pleated sheet configuration of amyloid may be involved in both occasional permanganate resistance and the SH method negativity.

The size of the AA protein bands in our study, ranging around 9–13 kd, is as expected for AA proteins, based on previous publications.18,23,32,49,52 In the two cheetahs, the dog, cat II, cow I, the chicken, and the turaco (case Nos. 11–13, 15, 17, 26, 27), the two MW bands that were demonstrated on the SDS-PAGE gel are both probably fragments originating from the specific precursor SAA protein (Table 2 and published data11,33,36). A similar phenomenon was widely described in reactive amyloidosis in humans.11,36,43

The high homology between human and animal AA allows one to view the study as further extending the range of the AA proteins recognized by the SH method and thus expanding its validity and reliability as a clinical and investigative tool. Similarly, resting on the high homology of the other analogous human and animal amyloid proteins, resistance of animal non-AA amyloid proteins to the SH method is also conceivable. However, this assumption still remains to be experimentally corroborated. The nonavailability for us of other types of animal amyloidosis precluded the demonstration of the specificity of the SH method to AA in animal amyloidosis.

Our study adds a supplementary tool to the spectrum of techniques used in the diagnosis of animal amyloidosis. Its advantage is that it does not require a wide array of specific antibodies, which are not commercially available, and may be performed outside of a histological laboratory, thus facilitating clinical decisions.


   References
Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 

  1. Aharon A, Langevitz P, Maran R, Blank-Porat D, Shtrasburg S, Livneh A: Reactive amyloidosis in a patient with Mycobacterium simiae pulmonary infection. Respir Med 92:123-124, 1998[Medline]
  2. Benharroch D, Sukenik S, Sacks M: Bronchioloalveolar carcinoma and generalized amyloidosis complicating progressive systemic sclerosis. Hum Pathol 23:839-841, 1992[CrossRef][ISI][Medline]
  3. Castano EM, Prelli F, Morelli L, Avagnina A, Kahn A, Frangione B: Immunoglobulin lambda light chains are the precursors of ureteral localized amyloidosis: a micro-method for extraction of amyloid. Amyloid. Int J Exp Clin Invest 4:253-258, 1997
  4. Cohen AS: Proteins of the systemic amyloidoses. Curr Opin Rheumatol 6:55-67, 1994[Medline]
  5. Cohen AS, Shirahama T: Animal model: spontaneous and induced amyloidosis. Am J Pathol 68:441-444, 1972[Medline]
  6. Coria F, Prelli F, Castaño EM, Larrondo-Lillo M, Fernandez-Gonzalez J, van Duinen SG, Bots GTAM, Luyendijk W, Shelanski ML, Frangione B: ß-protein deposition: a pathogenetic link between Alzheimer's disease and cerebral amyloid angiopathies. Brain Res 463:187-191, 1988[CrossRef][ISI][Medline]
  7. de Beer MC, de Beer FC, Beach CM, Gonnerman WA, Carreras I, Sipe JD: Syrian and Armenian hamsters differ in serum amyloid A gene expression. Identification of novel Syrian hamster serum amyloid A subtypes. J Immunol 150:5361-5370, 1993[Abstract]
  8. Elghetany MT, Saleem A: Methods for staining amyloid in tissues: a review. Stain Technol 63:201-212, 1988[ISI][Medline]
  9. Feiner HD: Pathology of dysproteinemia: light chain amyloidosis, non-amyloid immunoglobulin deposition disease, cryoglobulinemia syndromes and macroglobulinemia of Waldenstrom. Hum Pathol 19:1255-1272, 1988[Medline]
  10. Friedman E, Farfel Z, Goldfarb D, Gafni J: Renal tubular acidosis after prolonged remission of nephrotic syndrome in amyloidosis associated with astrocytoma. South Med J 82:765-768, 1989[Medline]
  11. Gal R, Shtrasburg S, Luria M, Lifschitz-Mercer B, Viskin S, Yakar S, Pras M: Amyloid goiter: report of the clinical histological and biochemical features of five cases. Amyloid. Int J Exp Clin Invest 2:119-125, 1995
  12. Gallo GR, Feiner HD, Chuba JV, Beneck D, Marion P, Cohen DH: Characterization of tissue amyloid by immunofluorescence microscopy. Clin Immunol Immunopathol 39:479-490, 1986[CrossRef][Medline]
  13. Gertz MA, Kyle RA: Secondary systemic amyloidosis: response and survival in 64 patients. Medicine 70:246-256, 1991[Medline]
  14. Gorevic PD, Greenwald M, Frangione B, Pras M, Franklin EC: The amino acid sequence of duck amyloid A (AA) protein. J Immunol 118:1113-1118, 1977[Abstract/Free Full Text]
  15. Gruys E, Snel FWJJ: Animal models for reactive amyloidosis. Bailliere's Clin Rheumatol 8:599-611, 1994[CrossRef][Medline]
  16. Husby G: Amyloidosis. Semin Arthritis Rheum 22:67-82, 1992[CrossRef][Medline]
  17. Husby G, Marhaug G, Dowton B, Sletten K, Sipe JD: Serum amyloid A (SAA): biochemistry, genetics and the pathogenesis of AA amyloidosis. Amyloid. Int J Exp Clin Invest 1:119-137, 1994
  18. Johnson KH, Sletten K, Munson L, O'Brien TD, Papendick R, Westermark P: Amino acid sequence analysis of amyloid protein A (AA) from cats (captive cheetahs: Acinonyx jubatus) with a high prevalence of AA amyloidosis. Amyloid. Int J Exp Clin Invest 4:171-177, 1997
  19. Johnson KH, Westermark P, Sletten K, O'Brien TD: Amyloid protein and amyloidosis in domestic animals. Amyloid. Int J Exp Clin Invest 3:270-289, 1996
  20. Kisilevsky R: Proteoglycans, glycosaminoglycans, amyloid-enhancing factor, and amyloid deposition. J Intern Med 232:515-516, 1992[Medline]
  21. Koren R, Livneh A, Shtrasburg S, Goldwasser B, Linke R, Gal R: Organ-limited amyloidosis of the deferent ducts, seminal vesicles and ejaculatory ducts. In: Amyloid and Amyloidosis, ed. Kyle RA, Gertz MA, pp 524-526, Parthenon, New York, NY 1998
  22. Laemmli UK: Cleavage of a structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685, 1970[CrossRef][Medline]
  23. Landman WJM, Sletten K, Koch CAM, Tooten PCJ, Gruys E: Chicken joint amyloid protein is of the AA-type. I. Characterization of the amyloid protein. Scand J Immunol 43:210-218, 1996[Medline]
  24. Levin M, Franklin EC, Frangione B, Pras M: The amino acid sequence of a major nonimmunoglobulin component of some amyloid fibrils. J Clin Invest 51:2773-2776, 1972
  25. Linke RP: Monoclonal antibodies against amyloid fibril protein AA. Production, specificity and use for immunohistochemical localization and classification of AA-type amyloidosis. J Histochem Cytochem 32:322-328, 1984[Abstract]
  26. Linke RP, Heilmann KS, Nathrath WBJ, Eulitz M: Identification of amyloid A protein in a sporadic Muckle-Wells syndrome. N-terminal amino acid sequence after isolation from formalin-fixed tissue. Lab Invest 48:698-704, 1983[ISI][Medline]
  27. Linke RP, Huhn D, Casanova S, Donini U: Methods in laboratory investigation. Immunoelectron microscopic identification of human AA-type amyloid: exploration of various monoclonal AA-antibodies, methods of fixation, embedding and of other parameters for the protein-A gold method. Lab Invest 61:691-697, 1989[ISI][Medline]
  28. Löfberg H, Thysell H, Westman K, Larsen S, Brun C, Gruic V, Grubb A: Demonstration and classification of amyloidosis in needle biopsies of the kidneys, with special reference to amyloidosis of the AA-type. Acta Pathol Microbiol Immunol Scand 95:357-363, 1987
  29. Looi LM: An investigation of the protein components of amyloid using immunoperoxidase and permanganate methods on tissue sections. Pathology 18:137-140, 1986[Medline]
  30. Mezza LE, Quimby FW, Durham SK, Lewis RM: Characterization of spontaneous amyloidosis of Syrian hamsters using the potassium permanganate method. Lab Anim Sci 34:376-380, 1984[Medline]
  31. Niewold TA, Murphy C, Gruys E: Hamster hepatic amyloid A (AA) protein is derived from a novel member of the SAA gene family. Scand J Immunol 39:225-227, 1994[Medline]
  32. Niewold TA, van der Linde-Sipman JS, Murphy C, Tooten PCJ, Gruys E: Familial amyloidosis in cats: Siamese and Abyssinian AA proteins differ in primary sequence and pattern of deposition. Amyloid. Int J Exp Clin Invest 6:205-209, 1999
  33. Ofri R, Nyska A, Linke RP, Shtrasburg S, Livneh A, Gal R: Systemic amyloidosis in a cheetah (Acinonyx jubatus). Amyloid. Int J Exp Clin Invest 4:98-103, 1997
  34. Picken MM, Pelton K, Frangione B, Gallo G: Primary amyloidosis A. Immunohistochemical and biochemical characterization. Am J Pathol 129:536-542, 1987[Abstract]
  35. Powers JM, Sullivan L, Rosenthal CJ: Permanganate oxidation of senile cerebral amyloid and its relationship to AA protein. Acta Neuropathol 58:275-278, 1982[Medline]
  36. Prelli F, Pras M, Frangione B: Degradation and deposition of amyloid AA fibrils are tissue specific. Biochemistry 26:8251-8256, 1987[CrossRef][Medline]
  37. Puchtler H, Sweat F, Levine M: On the binding of Congo red by amyloid. J Histochem Cytochem 10:355-364, 1962[Abstract]
  38. Robbins SL, Cotran RS, Kumar V: Pathologic Basis of Disease, 3rd ed. pp 158-213, Saunders, Philadelphia, PA 1984
  39. Röcken C, Schwotzer EB, Linke RP, Saeger W: The classification of amyloid deposits in clinicopathological practice. Histopathology 29:325-335, 1996[CrossRef][Medline]
  40. Scully RE, Mark EJ, McNeely WF, Ebeling SH, Phillips LD: Case records of the Massachusetts General Hospital, Case 20-1998. N Engl J Med 26:1905-1913, 1998
  41. Shtrasburg S, Gal R, Pras M: Crush and smear technique for rapid detection and semiquantitation of amyloid deposition. Biotech Histochem 66:203-207, 1991[Medline]
  42. Shtrasburg S, Livneh A, Gal R, Pras M: Extremely active murine amyloid enhancing factor. Clin Exp Rheumatol 14:37-42, 1996[Medline]
  43. Shtrasburg S, Livneh A, Pras M, Weinstein T, Gal R: Detection of serum Amyloid A-derived proteins in formalin-fixed paraffin-embedded tissues. Reliability of the method and expansion of its spectrum. Am J Clin Pathol 108:289-294, 1997[Medline]
  44. Shtrasburg S, Pras M, Brezniak N, Dolitzki M, Livneh A: Pregnancy and amyloidogenesis: I. Offspring of amyloidotic mice are not predisposed to develop amyloidosis. J Lab Clin Med 134:168-172, 1999[CrossRef][Medline]
  45. Shtrasburg S, Pras M, Brezniak N, Livneh A: Long term effects of amyloid enhancing factor: clinical and experimental implications. Clin Exp Rheumatol 16:299-302, 1998[Medline]
  46. Shtrasburg S, Pras M, Gal R, Salai M, Livneh A: Inhibition of the second phase of amyloidogenesis in a mouse model by a single-dose colchicine regimen. J Lab Clin Med 138:107-111, 2001[Medline]
  47. Shtrasburg S, Pras M, Langevitch P, Gal R: Demonstration of AA-protein in formalin-fixed, paraffin-embedded tissues. Am J Pathol 106:141-144, 1982[Abstract]
  48. Tan SY, Pepys MB: Amyloidosis. Histopathology 25:403-414, 1994[ISI][Medline]
  49. Waston G, Coade S, Woo P: Analysis of the genomic and derived protein structure of a novel human serum amyloid A gene, SAA4. Scand J Immunol 36:703-712, 1992[CrossRef][ISI][Medline]
  50. Westermark P, Nilsson GT: Demonstration of amyloid protein AA in old museum specimens. Arch Pathol Lab Med 108:217-219, 1984[Medline]
  51. Wright JR, Calkins E, Humphrey RL: Potassium permanganate reaction in amyloidosis. A histologic method to assist in differentiating forms of this disease. Lab Invest 36:274-281, 1977[ISI][Medline]
  52. Yakar S, Livneh A, Kaplan B, Pras M: The molecular basis of reactive amyloidosis. Semin Arthritis Rheum 24:255-261, 1995[CrossRef][Medline]
  53. Zwas ST, Shpilberg O, Huszar M, Rozenman J: Isolated ectopic lung uptake of technetium 99m methylene diphosphonate on bone scintigraphy in primary amyloidosis. Eur J Nucl Med 17:282-285, 1990[Medline]
Request reprints from Mr. S. Shtrasburg, Heller Institute of Medical Research, Sheba Medical Center, Tel Hashomer 52621 (Israel). E-mail: shmuels{at}sheba.health.gov.il





This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shtrasburg, S.
Right arrow Articles by Livneh, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shtrasburg, S.
Right arrow Articles by Livneh, A.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS